Prevymis (letermovir) - Merck (MSD)
A New Approach to an Old Foe: Letermovir for CMV Prophylaxis in Transplant Recipients. (PubMed, J Card Fail) - Feb 13, 2026 - No abstract available 
Journal • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/41679685
 
Evan P Kransdorf; Kevin Lor; Laura DiChiacchio; Rashmi Jain
 
Feb 13, 2026
 
Prev Next